Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95.5M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
15.2M
-
Shares change
-
-1.06M
-
Total reported value, excl. options
-
$308M
-
Value change
-
-$24.3M
-
Put/Call ratio
-
1.63
-
Number of buys
-
40
-
Number of sells
-
-36
-
Price
-
$20.21
Significant Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q1 2021
101 filings reported holding CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share as of Q1 2021.
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.2M shares
of 95.5M outstanding shares and own 15.96% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (5.12M shares), Capital International Investors (1.34M shares), CREDIT SUISSE AG/ (1.2M shares), CAPITAL INTERNATIONAL INC (913K shares), Sumitomo Mitsui Trust Holdings, Inc. (891K shares), Nikko Asset Management Americas, Inc. (891K shares), Capital World Investors (875K shares), Bpifrance SA (426K shares), FMR LLC (406K shares), and Capital Impact Advisors, LLC (347K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.